Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit

Circulation Research

Volumn 89, Issue 9, 2001, Pages 779-786

  Deindl, Elisabeth ^a   Buschmann, Ivo ^a   Hoefer, Imo E ^a   Podzuweit, Thomas ^a   Boengler, Kerstin ^a   Vogel, Sabina ^a   Van Royen, Niels ^a   Fernandez, Borja ^a   Schaper, Wolfgang ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Arteriogenesis; Hypoxia; Vascular endothelial growth factor

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; HYPOXANTHINE; HYPOXIA INDUCIBLE FACTOR 1; INOSINE; LACTATE DEHYDROGENASE; LACTIC ACID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTERY DIAMETER; ARTERY OCCLUSION; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; FEMORAL ARTERY; GENE INDUCTION; HIGH ENERGY PHOSPHATE; HUMAN; HUMAN CELL; HYPOXIA; IN SITU HYBRIDIZATION; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0035955749     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2101.098613     Document Type: Article

References (29)

1. Schaper W, Piek JJ, Munoz-Chapuli R, Wolf C, Ito W. Collateral circulation of the heart. In: Ware JA, Simons M, eds. Angiogenesis and Cardiovascular Disease. New York, NY/Oxford, UK: Oxford University Press; 1999:159-198.
2. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.
3. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LP, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis. J Clin Invest. 1994; 93:662-670.
4. Isner JM, Piezcek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischaemic limb. Lancet. 1996;348:370-374.
5. Henry TD, Annex BH, Azrin MA, McKendall GR, Willerson JT, Hendel RC, Giordano FJ, Klein R, Gibson CM, Berman DS, Luce CA, McCluskey ER. Double blind, placebo controlled trial of recombinant human vascular endothelial growth factor: the VIVA trial. J Am Coll Cardiol. 1999;33A:384. Abstract.
6. Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, Kedes LH, Kloner RA. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial model in the rat: angiogenesis and angioma formation. J Am Coll Cardiol. 2000;35:1323-1330.
7. Lazarous DF, Shou M, Stiber JA, Hodge E, Thirumurti V, Goncalves L, Unger EF. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Cardiovasc Res. 1999;44:294-302.
8. Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, Cook JJ. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res. 2001;49: 618-625.
9. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
10. Hoefer IE, van Royen N, Buschmann IR, Piek JJ, Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res. 2001;49:609-617.
11. Kanse SM, Wijelath E, Kanthou C, Newman P, Kakkar VV. The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with the endothelin receptor density. Lab Invest. 1995; 72:376-382.
12. Jaffe EA, Nachmen RL, Becker GC, Minick CR. Culture of human endothelial cells from umbilical veins. J Clin Invest. 1973;52:2745-2756.
13. Fischer S, Renz D, Schaper W, Karliczek GF. Barbiturates decrease the expression of vascular endothelial growth factor in hypoxic cultures of porcine brain derived microvascular endothelial cells. Mol Brain Res. 1998;60:89-97.
14. Podzuweit T, Beck H, Mueller A, Bader R, Goerlach G, Scheld HH. Absence of xanthine oxidoreductase activity in human myocardium. Cardiovasc Res. 1991;25:820-830.
15. Podzuweit T, Dalby AJ, Cherry GW, Opie LH. Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation. J Mol Cell Cardiol. 1978;10: 81-94.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
18. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 1992;114:521-532.
19. Aimee Y, Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol. 1998;275:818-826.
20. Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Wiesnet M, Busse R, Schaper J, Schaper W. Ultrastructure and molecular histology of rabbit hindlimb collateral artery growth (arteriogenesis). Virchows Arch. 2000; 436:257-270.
21. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem. 1997;272: 5375-5381.
22. Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol. 1997;273:H1255-H1265.
23. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A. 1998;95:15809-15814.
24. Lindner V, Reidy M. Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF. Arterioscler Thromb Vasc Biol. 1996;16:1399-1405.
25. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YCE, Olander JV, Connolly DT, Stem D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172:1535-1545.
26. Laitinen M, Zachary I, Breier G, Pakkanen T, Hakkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, Yla-Herttuala S. VEGF gene transfer reduces intimai thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther. 1997;8:1737-1744.
27. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1997;101:41-50.
28. Yang HT, Feng Y, Allen LA, Protter A, Terjung RL. Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency. Am J Physiol Heart Circ Physiol. 2000;278: H1966-H1973.
29. Rajanayagam MA, Shou M, Thirumurti V, Lazarous DF, Quyyumi AA, Concalves L, Stiber J, Epstein SE, Unger EF. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dog. J Am Coll Cardiol. 2000;35:519-526.